
Keywords: sCD163; soluble CD163; HCC; hepatocellular carcinoma; OS; overall survival; AFP; alpha-fetoprotein; CLIP; Cancer of the Liver Italian Program; BCLC; Barcelona Clinic Liver Cancer; CRP; C-reactive protein; NASH; non-alcoholic steatohepatitis; CK; cytokerat